Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quick-starting Estetrol/Drospirenone vs EE/Gestodene for Ovulation Inhibition
NCT06396221Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of estetrol and drospirenone in contraception (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Rate of ovulation inhibition. Started May 2024; status: completed.
02
Drugs
estetroldrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06396221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06396221.